Superstring Capital Management’s Keros Therapeutics KROS Stock Holding History

Superstring Capital Management’s Portfolio KROS Stock Details KROS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.5M	Buy
2024 Q3	–	Sell
2024 Q2	$3.39M	Buy
2024 Q1	$2.24M	Sell
2023 Q4	$2.97M	Buy